The group’s principle activity is to provide innovative molecular oncology testing services. The group operates through to divisions include Oncotech Clinical Laboratory and Oncotech Pharmaceutical Services. The group’s laboratory services include pathology diagnostic consultations, cytochemistry, immunophenotyping, fluorescence in Situ Hybridization and molecular diagnostics. The group operates from United States and Europe.
Executive Information
Name
Title
Email
William Ricketts
VP, Chief Scientific Officer
N/A
Hannah Mamuszka
Dir. - Scientific, Pharmaceutical Alliances
N/A
Mai Gu
Medical Dir.
N/A
Christine Wheeler
Pathologist
N/A
David Smith
Principal Research Scientist - Research & Development Division
